Th1/1型效应B细胞促炎细胞因子网络特征界定四种系统性自身免疫病的共同患者亚群
该多中心横断面研究纳入179例系统性自身免疫病患者和48名健康志愿者,检测细胞因子、自身抗体和循环免疫细胞等组学数据。研究发现以CXCL10、IL-6、IL-2和TNF高水平为特征的促炎细胞因子谱在四种疾病中界定出特定患者亚群,与更严重疾病和更高自身抗体水平相关,体外实验提示B细胞可增强Th1分化和1型效应B细胞诱导。
要点
- 高CXCL10、IL-6、IL-2、TNF的促炎特征在四种系统性自身免疫病中界定出共同患者亚群。
- 该促炎亚群与特定循环免疫细胞特征、更严重疾病和更高自身抗体水平相关。
- 体外实验显示B细胞增强Th1分化和初始T细胞增殖,诱导1型效应B细胞和IgG产生。
核心结论
- 基于促炎细胞因子谱可在四种系统性自身免疫病中识别出与更严重疾病相关的共同患者亚群。
- T细胞/B细胞交互作用揭示B细胞功能异质性,联合生物标志物可能有助于患者分层和个体化治疗设计。
研究设计与样本
- 多中心横断面PRECISE Systemic Autoimmune Diseases(PRECISESADS)研究,纳入179例患者和48名健康志愿者。
- 检测多低维组学数据包括细胞因子、自身抗体和循环免疫细胞,并进行共培养实验测试细胞因子微环境对T细胞/B细胞交互的影响。
主要发现
- 以CXCL10、IL-6、IL-2和TNF高水平定义的促炎细胞因子谱在四种系统性自身免疫病中界定出特定患者组。
- 每种疾病中该促炎簇与特定循环免疫细胞特征、更严重疾病和更高自身抗体水平相关,提示不受控的促炎Th1免疫反应。
- 体外观察到B细胞增强Th1分化和初始T细胞增殖,诱导1型效应B细胞和IgG产生,伴随CXCL10、IL-6、IL-2和干扰素-γ产生增加。
临床怎么用
- 可考虑检测CXCL10、IL-6、IL-2和TNF等细胞因子谱以识别系统性自身免疫病中疾病更严重的促炎亚群。
- 联合细胞因子、自身抗体和免疫细胞标志物可能有助于患者分层和个体化治疗设计。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The effector T cell and B cell cytokine networks have been implicated in the pathogenesis of systemic autoimmune diseases, but the association of these cytokine networks with the heterogeneity of clinical manifestations and immune profiles has not been carefully examined. This study was undertaken to examine whether cytokine profiles can delineate distinct groups of patients in 4 systemic autoimmune diseases (systemic lupus erythematosus, Sjögren's syndrome, rheumatoid arthritis, and systemic sclerosis). METHODS: A total of 179 patients and 48 healthy volunteers were enrolled in the multicenter cross-sectional PRECISE Systemic Autoimmune Diseases (PRECISESADS) study. Multi-low-dimensional omics data (cytokines, autoantibodies, circulating immune cells) were examined. Coculture experiments were performed to test the impact of the cytokine microenvironment on T cell/B cell cross-talk. RESULTS: A proinflammatory cytokine profile defined by high levels of CXCL10, interleukin-6 (IL-6), IL-2, and tumor necrosis factor characterized a distinct group of patients in the 4 systemic autoimmune diseases. In each disease, this proinflammatory cluster was associated with a specific circulating immune cell signature, more severe disease, and higher levels of autoantibodies, suggesting an uncontrolled proinflammatory Th1 immune response. We observed in vitro that B cells reinforce Th1 differentiation and naive T cell proliferation, leading to the induction of type 1 effector B cells and IgG production. This process was associated with an increase in CXCL10, IL-6, IL-2, and interferon-γ production. CONCLUSION: This composite analysis brings new insights into human B cell functional heterogeneity based on T cell/B cell cross-talk, and proposes a better stratification of patients with systemic autoimmune diseases, suggesting that combined biomarkers would be of great value for the design of personalized treatments.
引用
- Simon Q, Grasseau A, Boudigou M, et al. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases. Arthritis Rheumatol. 2021. PMID: 33605069. doi:10.1002/art.41697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。